Insider Sale: Director Judy Olian Sells Shares of United Therapeutics Corp (UTHR)
Insider Sale: Director Christopher Causey Sells Shares of United Therapeutics Corp (UTHR)
United Therapeutics Corp (UTHR) Q1 2024 Earnings Call Transcript Highlights: Record Revenue and Strategic Advances
Q1 2024 United Therapeutics Corp Earnings Call Transcript
Decoding United Therapeutics Corp (UTHR): A Strategic SWOT Insight
United Therapeutics Surpasses Analyst Revenue Forecasts with Strong Q1 2024 Performance
CORRECTING and REPLACING PHOTO United Therapeutics Announces World's First Successful Xenothymokidney Transplant
United Therapeutics Announces World's First Successful Xenothymokidney Transplant
United Therapeutics Corporation to Report First Quarter 2024 Financial Results Before the Market Opens on Wednesday, May 1, 2024
United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the American Thoracic Society 2024 International Conference
Insider Sell: Chairperson & CEO Martine Rothblatt Sells 30,000 Shares of United Therapeutics Corp (UTHR)
Insider Sell: EVP & GENERAL COUNSEL Paul Mahon Sells 6,000 Shares of United Therapeutics Corp (UTHR)
United Therapeutics Corp (UTHR) Chairperson & CEO Martine Rothblatt Sells 30,000 Shares
United Therapeutics Corp (UTHR) Chairperson & CEO Martine Rothblatt Sells 29,125 Shares
Why Is Jazz (JAZZ) Up 1.3% Since Last Earnings Report?
Why Is Esperion Therapeutics (ESPR) Up 2% Since Last Earnings Report?
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
United Therapeutics Corp (UTHR) CEO Martine Rothblatt Sells 30,000 Shares
Merck (MRK) Gets FDA Approval for New PAH Drug Winrevair
United Therapeutics' Robust Portfolio Fuels Double-Digit Growth
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.